SCHEMBL21315862

SCHEMBL21315862

CC(C)(O)c1ccccc1Nc1ccc2c(c1)sc1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GPR3 P46089 1/20 0.38
▸ PTGIR P43119 1/20 0.37
▸ PTPN7 P35236 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ PTPN12 Q05209 1/20 0.36
▸ PTPN22 Q9Y2R2 1/20 0.36
▸ IDO1 P14902 5/20 0.35
▸ DHODH Q02127 1/20 0.34
▸ PARP14 Q460N5 1/20 0.33
▸ GRM4 Q14833 1/20 0.32
▸ PLAU P00749 1/20 0.32
▸ TAS2R14 Q9NYV8 1/20 0.32
▸ TDO2 P48775 2/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17283743 0.77 GPR3 (0.58) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL14866199 0.76 KDM4E (0.51) MAPTALDH1A1HPGDRAB9AGPR3
SCHEMBL17283591 0.76 ALDH1A1 (0.54) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL18201519 0.76 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL26634483 0.75 PTGIR (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL16657835 0.74 ALDH1A1 (0.44) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL28667623 0.74 ALDH1A1 (0.44) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL21315867 0.74 MAPT (0.57) MAPTALDH1A1HPGDDHODH
SCHEMBL17363312 0.73 MAPT (0.42) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL22783424 0.73 GPR3 (0.52) MAPTALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11005047-B2 Heteroaromatic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-05-11 — — US disclosed
US-11005047-B2 Heteroaromatic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-05-11 — — US disclosed
US-10844043-B2 Heteroaromatic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2020-11-24 — — US disclosed
US-10844043-B2 Heteroaromatic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2020-11-24 — — US disclosed
US-20190348609-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-11-14 — — US disclosed
US-20190348609-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-11-14 — — US disclosed
US-20190322641-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-10-24 — — US disclosed
US-20190273210-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-09-05 — — US disclosed
US-20190273210-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844043-B2 Heteroaromatic compound and organic electroluminescence device using the same VDAC1, TRPC6, TRPC5 MAPT 1876/4885ALDH1A1 578/4885HPGD 1762/4885
US-11005047-B2 Heteroaromatic compound and organic electroluminescence device using the same ARNT, TRPC6, DDT MAPT 1888/4885ALDH1A1 486/4885HPGD 1168/4885
US-20190322641-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME VDAC1, TRPC6, TRPC5 MAPT 1876/4885ALDH1A1 578/4885HPGD 1762/4885
US-20190348609-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ARNT, TRPC6, DDT MAPT 1888/4885ALDH1A1 486/4885HPGD 1168/4885
US-20190273210-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME VDAC1, TRPC6, TRPC5 MAPT 1876/4885ALDH1A1 578/4885HPGD 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback